LENZ

LENZ Therapeutics

63 hedge funds and large institutions have $80.7M invested in LENZ Therapeutics in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

57% less capital invested

Capital invested by funds: $186M → $80.7M (-$105M)

72% less call options, than puts

Call options by funds: $59K | Put options by funds: $210K

Holders
63
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$59K
Puts
$210K
Net Calls
Net Calls Change

Top Buyers

1 +$3.02M
2 +$2.17M
3 +$1.58M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.2M
5
Millennium Management
Millennium Management
New York
+$1.11M

Top Sellers

1 -$13.8M
2 -$9.13M
3 -$8.22M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.54M
5
BlackRock
BlackRock
New York
-$3.32M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$23.3M
2
$14.4M
3
$3.63M
4
$3.2M
5
$3.02M
6
$2.93M
7
$2.9M
8
$2.17M
9
$1.98M
10
$1.95M
11
$1.93M
12
$1.93M
13
$1.58M
14
$1.45M
15
$1.34M
16
$1.26M
17
$1.2M
18
$1.15M
19
$1.12M
20
$1.1M
21
$948K
22
$825K
23
$702K
24
$659K
25
$549K